MIVI Neuroscience Secures Series B Funding News provided by Share this article Share this article EDEN PRAIRIE, Minn., Jan. 21, 2021 /PRNewswire/ -- MIVI Neuroscience, a medical device company focused on improving clinical outcomes for ischemic stroke patients, today announced the closing of its Series B funding including $35 million in new money plus the conversion of previously issued convertible notes. The funding was led by a major multinational med-tech company and included participation from new investors Perceptive Advisors, Deerfield Management and Aphelion / Cardeation Capital as ...